Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1618
This examiner grants 52% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19240908 | METHOD OF TREATING PROSTATE CANCER | Final Rejection | Novartis AG |
| 18080346 | METHODS AND MATERIALS FOR TREATING HYPOCAPNIA | Final Rejection | Mayo Foundation for Medical Education and Research |
| 19280749 | COMPOSITIONS USING IRON EXCIPIENTS AND THEIR USES INCLUDING FOR THE TREATMENT OF CANCER | Final Rejection | Zetagen Therapeutics, Inc. |
| 18062577 | HEMOSTATIC MATERIAL COMPOSITION | Non-Final OA | FUJIFILM CORPORATION |
| 17884998 | SYNTHESIS AND COMPOSITION OF AMINO ACID LINKING GROUPS CONJUGATED TO COMPOUNDS USED FOR THE TARGETED IMAGING OF TUMORS | Non-Final OA | Purdue Research Foundation |
| 17040967 | METHODS AND ASSAYS FOR MODULATING GENE TRANSCRIPTION BY MODULATING CONDENSATES | Non-Final OA | Massachusetts Institute of Technology |
| 19231931 | Stable, concentrated radionuclide complex solutions | Non-Final OA | Advanced Accelerator Applications SA |
| 19210753 | METHODS FOR TREATING PROSTATE CANCER WITH RADIOPHARMACEUTICALS | Final Rejection | ARTBIO, Inc. |
| 19202402 | MYOCARDITIS-TARGETED RADIONUCLIDE MOLECULAR PROBE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | Non-Final OA | Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology |
| 18990863 | IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING FIBROBLAST-ACTIVATION PROTEIN-ALPHA (FAP-ALPHA) | Non-Final OA | The Johns Hopkins University |
| 16608021 | METHODS AND AGENTS FOR THE DETECTION AND TREATMENT OF CANCER | Non-Final OA | CASE WESTERN RESERVE UNIVERSITY |
| 18969629 | Stable Soft Chews, and Methods to Produce Same | Non-Final OA | Florida Research Group, LLC |
| 17605846 | Implantable Device Coated by a Self-Assembled Monolayer and Therapeutic Agent | Non-Final OA | Duquesne University of the Holy Spirit |
| 17052928 | TETRAZINES FOR HIGH CLICK CONJUGATION YIELD IN VIVO AND HIGH CLICK RELEASE YIELD | Non-Final OA | Tagworks Pharmaceuticals B.V. |
| 17522249 | SUBSTITUTED ORGANOFLUOROBORATES AS IMAGING AGENTS | Non-Final OA | THE UNIVERSITY OF BRITISH COLUMBIA |
| 18477504 | HIGH PURITY COPPER RADIOPHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF | Non-Final OA | University of Basel |
| 18320890 | METHODS FOR MAKING ULTRASOUND CONTRAST AGENTS | Non-Final OA | Lantheus Medical Imaging, Inc. |
| 18015114 | COATED SUBSTRATES AND METHOD OF MAKING SAME | Final Rejection | Cotex Technologies Inc. |
| 17553462 | RADIOLABELED COMPOUNDS AND USES THEREOF | Non-Final OA | The Research Foundation for Mental Hygiene, Inc. |
| 17696315 | FLUORESCENT PROBES FOR IDENTIFICATION AND QUANTIFICATION OF HEPATIC TRANSPORTERS IN VITRO AND IN VIVO | Non-Final OA | Starlight |
| 17477419 | COMPOSITIONS, COMBINATIONS AND RELATED METHODS FOR PHOTOIMMUNOTHERAPY | Final Rejection | Rakuten Medical, Inc. |
| 17511642 | Radioactive Phospholipid Metal Chelates for Cancer Imaging and Therapy | Non-Final OA | Wisconsin Alumni Research Foudation |
| 17111158 | DIAGNOSIS AND TREATMENT FOR RESPIRATORY TRACT DISEASES | Non-Final OA | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AF |
| 17048072 | ANTIBODIES FOR CHELATED RADIONUCLIDES AND CLEARING AGENTS | Non-Final OA | Orano Med SAS |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy